As doctors become more fearful of medical error, the open culture we need to learn from mistakes will slip further away […]
Featured
Tom Jefferson: How Cochrane is doing pharma a good turn
The way in which Cochrane produces its reviews is a boon to pharma, says Tom Jefferson […]
Engaging communities in tuberculosis research: The experience of the TB-PRACTECAL trial
In the wake of the 49th Union World Conference on lung health, multidrug resistant tuberculosis (MDR-TB) remains a major global public health threat. It was responsible for 230 000 deaths […]
Elly Nott: Training Idlib’s obstetricians
Giving birth is one of the most vulnerable moments a woman can experience. It can be anxiety-inducing enough in a well-equipped hospital in the UK, but the women of Idlib, […]
Benjamin Mazer: Are medical errors a huge problem that’s simple to fix?
Progress in patient safety can only come from the slow work of science and the honesty of our limitations […]
Peter C Gøtzsche: Cochrane—no longer a Collaboration
Peter C Gøtzsche discusses his expulsion from the Cochrane Collaboration […]
Frank Gavin: Helping patients understand adverse drug reactions
Adverse drug reactions (ADRs), or side effects, are important to patients. This became very clear to me in the six years when I served as a public member of the […]